Politics · 1 sources covering this

Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing

Novo Nordisk and Eli Lilly are battling for dominance in one of medicine’s largest and fastest-growing markets: drugs for obesity and weight loss. On Monday, Novo announced encouraging results for its experimental drug CagriSema. In a Phase 3 study of patients with type 2 diabetes, CagriSema produced 12.4% average weight loss after 60 weeks, compared […]

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Washington ExaminerLean R·1h ago
Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing
Novo Nordisk and Eli Lilly are battling for dominance in one of medicine’s largest and fastest-growing markets: drugs for obesity and weight loss. On Monday, Novo announced encouraging results for its experimental drug CagriSema. In a Phase 3 study of patients with type 2 diabetes, CagriSema produced 12.4% average weight loss after 60 weeks, compared […]
Read at Washington Examiner →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/4e849a937a8693f1a00e7d7df8152f8c8c5a91eb"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing"></iframe>

Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing

How 1 sources are covering this